US Stock MarketDetailed Quotes

ITCI Intra-Cellular Therapies

Watchlist
  • 83.450
  • -0.690-0.82%
Close Dec 20 16:00 ET
  • 83.450
  • 0.0000.00%
Post 20:01 ET
8.85BMarket Cap-95.92P/E (TTM)

Intra-Cellular Therapies Key Stats

Intra-Cellular Therapies Q3 2024 Earnings Date

Currency:USDOct 30, 2024

Estimate
(YoY)
Actual
(YoY)
Vs Estimate
(% Chg)
Revenue
172.35M
175.38M
+3.02M
Beat Est.
+36.60%
+39.00%
+1.75%
EPS
-0.21
-0.25
-0.04
Miss Est.
+16.37%
--
-19.62%
Strong Buy

Dec 5, 2024

Intra-Cellular Therapies Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 7 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 197.759M--
--2024/Q4-- / 194.051M--
Oct 30, 20242024/Q3175.375M / 172.353M--
Aug 7, 20242024/Q2161.388M / 157.884M--
May 7, 20242024/Q1144.866M / 141.444M--
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 197.759M--
--2024/Q4-- / 194.051M--
Oct 30, 20242024/Q3175.375M / 172.353M--
Aug 7, 20242024/Q2161.388M / 157.884M--
May 7, 20242024/Q1144.866M / 141.444M--

Unlock Free Earnings Estimates

Intra-Cellular Therapies Earnings Reports

Read more

Trending US Stocks
U.S Tech Companies U.S Tech Companies

U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data. U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data.

Analysis

Analyst Rating

Updated: Dec 5, 2024

Strong Buy

  • Buy

    85.71%
  • Hold

    14.29%
  • Sell

    0.00%

Price Target

No Data